Interestingly, in the current study, no differences in MEF2D and YY1 were observed in the diaphragms between COPD patients and control subjects, while a significant rise in MEF2C was, indeed, seen in the patients. The gene discussed is MEF2C; the disease is chronic obstructive pulmonary disease.